// App-Quantinova.ai

Filters

Biomarkers

No records found for your search

Conference Name

No records found for your search

Country

























Company

Search valid company name..

Conference Year













Drug











Disease

Medical Centers

Search valid medical center name..

Outcomes





Presenter

Search valid presenter name..

Principal Investigators

Search valid principal investigator name..

Phase










Patient Segments

Search valid patient segment..

Result



Sponsor

Search valid sponsor name..

Study ID

Search your valid Study ID..

Therapeutic Area
























28841 Abstracts

Complex Internal Carotid Artery T Occlusion By Computed Tomographic Angiography Is A Very Malignant Subtype With Massive Infarcts And Poor Outcomes Despite Revascularization Treatment

Ji Man Hong - American Heart Association (AHA) , 2015

Therapeutic Area

Disease

Drug/Treatment

Genetic Disorder

Ischemic stroke

N/A

Should Blood Pressure Targets After Lacunar Stroke Vary by Body Size? The SPS3 Trial

Leslie A McClure - American Heart Association (AHA) , 2015

Therapeutic Area

Disease

Drug/Treatment

Central Nervous System (CNS)

Stroke

N/A

Combining Conventional MRI-DWI With Advanced Quantitative T2 Imaging For Characterizing Extent Of Infarction In Ischemic Stroke: The Heterogeneity Of The Evolving Ischemic Lesion

Robert Kosior - American Heart Association (AHA) , 2015

Therapeutic Area

Disease

Drug/Treatment

Central Nervous System (CNS)

Ischemic stroke

N/A

Poor Collateral Circulation Assessed By Multiphase Cta Predicts Malignant Mca Evolution After Reperfusion Therapies

Marta Rubiera - American Heart Association (AHA) , 2015

Therapeutic Area

Disease

Drug/Treatment

Central Nervous System (CNS)

Stroke

N/A

Regional Vascular Status On Multi-phase CTA Correlates Well With Regional CT Perfusion Estimates And Final Tissue Fate

Seong Hwan Ahn - American Heart Association (AHA) , 2015

Therapeutic Area

Disease

Drug/Treatment

Genetic Disorder

Ischemic stroke

N/A

Baseline Variables Have Little Influence on Early Change in Neurological Status (?NIHSS) After Acute Ischemic Stroke: Basis For a Genetic Study

Carlos Cruchaga - American Heart Association (AHA) , 2015

Therapeutic Area

Disease

Drug/Treatment

Genetic Disorder

Ischemic stroke

N/A

Baseline Predictors of the Malignant Collateral Profile in IMS III

Tudor G Jovin - American Heart Association (AHA) , 2015

Therapeutic Area

Disease

Drug/Treatment

Central Nervous System (CNS)

Hypertension

N/A

Newton - Nimodipine Microparticles To Enhance Recovery While Reducing Toxicity After Subarachnoid Hemorrhage

Nima Etminan - American Heart Association (AHA) , 2015

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Subarachnoid hemorrhage

Nimodipine

Combined Lysis of Thrombus with Ultrasound and Systemic Tissue Plasminogen Activator for Emergent Revascularization in Acute Ischemic Stroke

Peter D. Schellinger - American Heart Association (AHA) , 2015

Therapeutic Area

Disease

Drug/Treatment

Genetic Disorder

Ischemic stroke

N/A

Using The M2 Vessel Diameter And Baseline NIHSS To Identify Which M2 Occlusions Should Be Treated Endovascularly?

Bijoy K Menon - American Heart Association (AHA) , 2015

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

A Phase III Clinical Trial To Evaluate The Reversal Effects Of Idarucizumab On Active Dabigatran (RE-VERSE AD)

R Dubiel - American Heart Association (AHA) , 2015

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

Pradax

DAWN TRIAL: DWI or CTP Assessment with Clinical Mismatch in the Triage of Wake Up and Late Presenting Strokes Undergoing Neurointervention

Jeffrey L. Saver - American Heart Association (AHA) , 2015

Therapeutic Area

Disease

Drug/Treatment

Central Nervous System (CNS)

Ischemic stroke

N/A

Carotid Revascularization Endarterectomy Vs Stenting Trial (CREST): Progress Toward Publication Of 10-year Results

Rutgers - American Heart Association (AHA) , 2015

Therapeutic Area

Disease

Drug/Treatment

Central Nervous System (CNS)

Restenosis

stannous fluoride

Clinical Effectiveness of Statin Therapy After Ischemic Stroke: Primary Results From the PROSPER Study

Melissa A. Greiner - American Heart Association (AHA) , 2015

Therapeutic Area

Disease

Drug/Treatment

Genetic Disorder

Intracerebral hemorrhage

N/A

Clues to Attenuating Plaque Inflammation: Heat Shock Protein-27 Augments Macrophage Histone Deacetylase-6 Activity and Cytoskeletal Migratory Capacity

Daiana Alvarez-Omeldo - American Heart Association (AHA) , 2015

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

Cost-effectiveness of Endovascular Therapy vs. IV t-PA Alone at 12 Months: The IMS III Trial Economic Follow-up Results

Annie N Simpson - American Heart Association (AHA) , 2015

Therapeutic Area

Disease

Drug/Treatment

Central Nervous System (CNS)

Stroke

N/A

NADPH Oxidase Nox4 Up-regulation Contributes to the Worsening of Pressure Overload-induced Cardiac Dysfunction in Angiopoeitin-like 2 Knockdown Mice

Adeline Raignault - American Heart Association (AHA) , 2015

Therapeutic Area

Disease

Drug/Treatment

Genetic Disorder

Vasodilation dysfunction

N/A

Cardiorenal Syndrome Arising From Chronic Diabetes Causes Maladaptive Carbohydrate Utilisation in the Heart and Kidneys

Antoinette Bugyei-Twum - American Heart Association (AHA) , 2015

Therapeutic Area

Disease

Drug/Treatment

Endocrine/metabolic Diseases (ME)

Cardiorenal syndrome

N/A

Mast Cells Promote Proliferation and Suppress Myogenic Differentiation of Mesenchymal Stem Cells

Nathan C. Ni - American Heart Association (AHA) , 2015

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Post-myocardial infarction

N/A

Molecular Regulation of Novel Pro-survival Bnip3 Spliced Variant Niplet in Cardiac Myocytes Functionally Couples Er and Mitochondria

Hongying Gang - American Heart Association (AHA) , 2015

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

Copyright © 2026. QuantiNova All rights reserved